MatsukiyoCocokara & Co. (TYO:3088)
Japan · Delayed Price · Currency is JPY 2,950.00
+135.00 (4.80%)
Nov 21, 2025, 3:30 PM JST
MatsukiyoCocokara & Co. Revenue
MatsukiyoCocokara & Co. had revenue of 275.45B JPY in the quarter ending September 30, 2025, with 3.56% growth. This brings the company's revenue in the last twelve months to 1.08T, up 4.28% year-over-year. In the fiscal year ending March 31, 2025, MatsukiyoCocokara & Co. had annual revenue of 1.06T with 3.82% growth.
Revenue (ttm)
1.08T
Revenue Growth
+4.28%
P/S Ratio
1.08
Revenue / Employee
85.08M
Employees
12,753
Market Cap
1.17T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.06T | 39.10B | 3.82% |
| Mar 31, 2024 | 1.02T | 71.28B | 7.49% |
| Mar 31, 2023 | 951.25B | 221.28B | 30.31% |
| Mar 31, 2022 | 729.97B | 173.06B | 31.08% |
| Mar 31, 2021 | 556.91B | -33.69B | -5.70% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Takeda Pharmaceutical Company | 4.42T |
| Otsuka Holdings | 2.42T |
| Astellas Pharma | 2.01T |
| Daiichi Sankyo Company | 1.98T |
| Chugai Pharmaceutical | 1.21T |
| Terumo | 1.06T |
| Olympus | 977.65B |
| HOYA Corporation | 892.50B |